|
| Status |
Public on Aug 18, 2022 |
| Title |
CT13 |
| Sample type |
SRA |
| |
|
| Source name |
AB1-HA tumor
|
| Organism |
Mus musculus |
| Characteristics |
tissue: tumor
strain: BALB/c
age: 8-10 weeks
gender: m
response: CR
timepoint: Day-1
|
| Treatment protocol |
200 mg/kg cyclophosphamide on day 10. Surgery was performed to excise analysed tumor on day 9, day 13 or day 17.
|
| Growth protocol |
subcutaneous tumor growth
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Frozen tumour dissociation with Trizol followed by chloroform extraction and purification using RNeasy MinElute
Illumina 50bp single-end sequencing
|
| |
|
| Library strategy |
RNA-Seq |
| Library source |
transcriptomic |
| Library selection |
cDNA |
| Instrument model |
Illumina HiSeq 2000 |
| |
|
| Data processing |
read alignment with Kallisto
count quantification with tximport
Genome_build: GRCm38.p6
Supplementary_files_format_and_content: count matrix with counts generated from txi import on kallisto aligned samples
|
| |
|
| Submission date |
Aug 24, 2021 |
| Last update date |
Aug 18, 2022 |
| Contact name |
Caitlin M Tilsed |
| Organization name |
NCARD,UWA
|
| Street address |
6 Verdun St
|
| City |
Nedlands |
| State/province |
WA |
| ZIP/Postal code |
6009 |
| Country |
Australia |
| |
|
| Platform ID |
GPL13112 |
| Series (1) |
| GSE182674 |
Bulk RNAseq of AB1-HA murine mesothelioma tumors from complete responders and partial responders to cyclophosphamide chemotherapy |
|
| Relations |
| BioSample |
SAMN20960104 |
| SRA |
SRX11895931 |
